VolitionRx (VNRX) Competitors

Terns Pharmaceuticals (NASDAQ:TERN) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, community ranking, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Do analysts prefer TERN or VNRX?

Terns Pharmaceuticals presently has a consensus price target of $18.38, suggesting a potential upside of 665.63%. VolitionRx has a consensus price target of $3.33, suggesting a potential upside of 584.46%. Given Terns Pharmaceuticals' higher possible upside, research analysts plainly believe Terns Pharmaceuticals is more favorable than VolitionRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Terns Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
VolitionRx	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Is TERN or VNRX more profitable?

Terns Pharmaceuticals has a net margin of 0.00% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Terns Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Terns Pharmaceuticals	N/A	-32.76%	-31.33%
VolitionRx	-2,321.14%	N/A	-163.39%

Which has stronger valuation & earnings, TERN or VNRX?

VolitionRx has higher revenue and earnings than Terns Pharmaceuticals. Terns Pharmaceuticals is trading at a lower price-to-earnings ratio than VolitionRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Terns Pharmaceuticals	N/A	N/A	-$90.21M	-$1.13	-2.12
VolitionRx	$1.23M	39.78	-$35.32M	-$0.31	-1.57

Does the media favor TERN or VNRX?

In the previous week, VolitionRx had 1 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 4 mentions for VolitionRx and 3 mentions for Terns Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 1.11 beat VolitionRx's score of 0.52 indicating that Terns Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Terns Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
VolitionRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, TERN or VNRX?

Terns Pharmaceuticals has a beta of -0.13, indicating that its share price is 113% less volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.

Do insiders & institutionals believe in TERN or VNRX?

98.3% of Terns Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.1% of VolitionRx shares are owned by institutional investors. 15.1% of Terns Pharmaceuticals shares are owned by company insiders. Comparatively, 12.8% of VolitionRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor TERN or VNRX?

Terns Pharmaceuticals received 29 more outperform votes than VolitionRx when rated by MarketBeat users. Likewise, 59.15% of users gave Terns Pharmaceuticals an outperform vote while only 19.70% of users gave VolitionRx an outperform vote.

Company	Underperform	Outperform
Terns Pharmaceuticals	Outperform Votes 42 59.15%	Underperform Votes 29 40.85%
VolitionRx	Outperform Votes 13 19.70%	Underperform Votes 53 80.30%

Summary

Terns Pharmaceuticals and VolitionRx tied by winning 8 of the 16 factors compared between the two stocks.